Press News | 26.05.2026
| Title | Media | Publ. Date |
| Greece is winning the battle against childhood obesity | Apogevmatini | 26/05/2026 |
| Mr. Olympios Papadimitriou is stepping down from Novo Nordisk | Kathimerini | 26/05/2026 |
| Internal oversight in the public sector is nonexistent | Kathimerini | 26/05/2026 |
| Crete’s hospitals are facing serious difficulties | Kathimerini | 26/05/2026 |
| The state’s debts to private individuals have skyrocketed to 3.9 billion euros | Naftemporiki | 26/05/2026 |
| The introduction of the new medicines is on hold | Ta Nea | 26/05/2026 |
| Public sector: The words “oversight” and “transparency” are unknown | Ta Nea | 26/05/2026 |
See here the publicity
Web Monitoring Report for the period 25/05 – 26/05
| Title | Media | Publ. Date |
| The requests of pharmaceutical companies concerning innovative medicines | capital.gr | 26/05/2026 |
| SFEE: Patients are being deprived of access to new medicines – availability can be delayed by up to two years | cnn.gr | 25/05/2026 |
| Pharmaceutical expenditure has surged to €8.1 billion amid a lack of oversight and the absence of effective measures | healthreport.gr | 26/05/2026 |
| Innovative treatments: A two-year wait in Greece for 20% of medicines | in.gr | 26/05/2026 |
| Greeks will wait more than 2 years for the new innovative medicines | naftemporiki.gr | 26/05/2026 |
| Fewer medicines and longer delays will result from the changes to the reimbursement framework, warns SFEE | news4health.gr | 26/05/2026 |
| Greek patients wait up to two years for innovative medicines | protothema.gr | 26/05/2026 |
| Access to new medicines is being restricted: Why 3 out of 5 will never become available in Greece | tovima.gr | 26/05/2026 |
